The lymphocyte-specific immunoglobulin heavy-chain gene intronic enhancer is regulated by multiple nuclear factors. The previously defined minimal enhancer containing the A, E3, and B sites is transactivated by a combination of the ETS-domain proteins PU.1 and Ets-1 in nonlymphoid cells. The core GGAAs of the A and B sites are separated by 30 nucleotides, suggesting that ETS proteins bind to these sites from these same side of the DNA helix. We tested the necessity for appropriate spatial alignment of these elements by using mutated enhancers with altered spacings. A 4-or 10-bp insertion between E3 and B inactivated the enhancer in S194 plasma cells but did not affect in vitro binding of Ets-1, PU.1, or the E3-binding protein TFE3, alone or in pairwise combinations. Circular permutation and phasing analyses demonstrated that PU.1 binding but not TFE3 or Ets-1 bends enhancer DNA toward the major groove. We propose that the requirement for precise spacing of the A and B elements is due in part to a directed DNA bend induced by PU.1.A key molecular event in B-cell development is the activation of immunoglobulin (Ig) heavy-chain () gene rearrangements in the earliest discernible B-cell precursor. Correlation of transcription activation with V(D)J recombination (1, 5) implicated the enhancer, located between the J H and C exons, as the probable regulatory target directing Ig heavychain gene recombination. The involvement of the enhancer in recombination and transcriptional activation was supported by the observation of sterile transcripts that initiated within the enhancer (31) and by the analysis of recombination substrates in cell lines (44) and transgenic mice (10). Furthermore, a role for this enhancer in regulating accessibility was suggested by the studies of Jenuwein et al. (23), who showed that a transgenic enhancer conferred access of bacterial RNA polymerases to adjacent DNA. Recently, genetic disruption of the enhancer in mice (8, 51) has directly demonstrated a role for this enhancer in Ig heavy-chain gene rearrangement.The enhancer contains binding sites for multiple nuclear factors (32, 41). Three known elements, A, B, and octamer, bind proteins with restricted tissue distribution. In contrast, the majority of the factors that bind to the E1 to E5 sites in the enhancer can be detected in extracts made from B cells as well as nonlymphoid cells. These factors, including the E2A gene products, belong to the basic helix-loop-helix (bHLH) family of transcription factors (37) and have been implicated in both positive and negative regulation of the enhancer. For example, the E5 motif that acts as a positive element in B cells (46) also interacts with a ubiquitous leucine zipper protein, ZEB, that has been proposed as a negative regulator of the enhancer (12). Secondly, in BxT somatic cell hybrids, where Ig heavy-chain expression is extinguished, one of the targets of repression is the E4 element of the enhancer (52). Finally, a mutation of the E2A (bHLH) gene by homologous recombination results in a developmen...